Ingalls & Snyder LLC Johnson & Johnson Transaction History

Ingalls & Snyder LLC

$2.56 Billion
Q3 2024

A detailed history of Ingalls & Snyder LLC transactions in Johnson & Johnson stock. As of the latest transaction made, Ingalls & Snyder LLC holds 91,210 shares of JNJ stock, worth $13.2 Million. This represents 0.58% of its overall portfolio holdings.

Number of Shares

91,210

Previous 92,162 1.03%

Holding current value

$13.2 Million

Previous $13.5 Million 9.73%

% of portfolio

0.58%

Previous 0.58%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$145.48 - $167.38 $138,496 - $159,345	-952 Reduced 1.03%	91,210 $14.8 Million
Q2 2024 Jul 31, 2024	SELL	$144.38 - $157.78 $273,600 - $298,993	-1,895 Reduced 2.01%	92,162 $13.5 Million
Q1 2024 May 13, 2024	SELL	$155.22 - $162.74 $122,002 - $127,913	-786 Reduced 0.83%	94,057 $14.9 Million
Q4 2023 Jan 29, 2024	SELL	$145.6 - $158.88 $597,542 - $652,043	-4,104 Reduced 4.15%	94,843 $14.9 Million
Q3 2023 Nov 02, 2023	SELL	$155.75 - $174.48 $2.5 Million - $2.8 Million	-16,048 Reduced 13.96%	98,947 $15.4 Million
Q2 2023 Jul 27, 2023	SELL	$154.35 - $166.11 $139,378 - $149,997	-903 Reduced 0.78%	114,995 $19 Million
Q1 2023 May 09, 2023	SELL	$151.05 - $180.26 $157,545 - $188,011	-1,043 Reduced 0.89%	115,898 $18 Million
Q4 2022 Jan 31, 2023	SELL	$160.2 - $179.79 $494,537 - $555,011	-3,087 Reduced 2.57%	116,941 $20.7 Million
Q3 2022 Oct 21, 2022	SELL	$161.33 - $179.52 $245,060 - $272,690	-1,519 Reduced 1.25%	120,028 $19.6 Million
Q2 2022 Aug 11, 2022	SELL	$168.19 - $186.01 $213,433 - $236,046	-1,269 Reduced 1.03%	121,547 $21.6 Million
Q1 2022 May 09, 2022	BUY	$158.14 - $179.59 $128,251 - $145,647	811 Added 0.66%	122,816 $21.8 Million
Q4 2021 Feb 11, 2022	SELL	$155.93 - $173.01 $934,644 - $1.04 Million	-5,994 Reduced 4.68%	122,005 $20.9 Million
Q3 2021 Oct 27, 2021	SELL	$161.5 - $179.47 $966,254 - $1.07 Million	-5,983 Reduced 4.47%	127,999 $20.7 Million
Q2 2021 Aug 03, 2021	SELL	$159.48 - $171.07 $1.33 Million - $1.43 Million	-8,359 Reduced 5.87%	133,982 $22.1 Million
Q1 2021 Apr 21, 2021	SELL	$153.07 - $170.48 $131,487 - $146,442	-859 Reduced 0.6%	142,341 $23.4 Million
Q4 2020 Jan 27, 2021	SELL	$137.11 - $157.38 $87,613 - $100,565	-639 Reduced 0.44%	143,200 $22.5 Million
Q3 2020 Oct 21, 2020	SELL	$140.38 - $153.83 $225,590 - $247,204	-1,607 Reduced 1.1%	143,839 $21.4 Million
Q2 2020 Jul 31, 2020	BUY	$128.81 - $155.51 $36,195 - $43,698	281 Added 0.19%	145,446 $20.5 Million
Q1 2020 Apr 22, 2020	SELL	$111.14 - $153.99 $835,439 - $1.16 Million	-7,517 Reduced 4.92%	145,165 $19 Million
Q4 2019 Jan 15, 2020	SELL	$127.5 - $146.44 $94,095 - $108,072	-738 Reduced 0.48%	152,682 $22.3 Million
Q3 2019 Oct 16, 2019	SELL	$126.95 - $142.14 $3 Million - $3.36 Million	-23,623 Reduced 13.34%	153,420 $19.8 Million
Q2 2019 Jul 11, 2019	SELL	$131.15 - $144.24 $199,872 - $219,821	-1,524 Reduced 0.85%	177,043 $24.7 Million
Q1 2019 Apr 11, 2019	SELL	$125.72 - $139.79 $264,640 - $294,257	-2,105 Reduced 1.17%	178,567 $25 Million
Q4 2018 Jan 24, 2019	SELL	$122.84 - $147.84 $347,514 - $418,239	-2,829 Reduced 1.54%	180,672 $23.3 Million
Q3 2018 Oct 24, 2018	SELL	$121.58 - $142.88 $183,464 - $215,605	-1,509 Reduced 0.82%	183,501 $25.4 Million
Q2 2018 Aug 10, 2018	BUY	$119.4 - $131.76 $563,926 - $622,302	4,723 Added 2.62%	185,010 $22.4 Million
Q1 2018 Apr 17, 2018	SELL	$125.1 - $148.14 $230,684 - $273,170	-1,844 Reduced 1.01%	180,287 $23.1 Million
Q4 2017 Jan 19, 2018	SELL	$131.22 - $143.62 $621,326 - $680,040	-4,735 Reduced 2.53%	182,131 $25.4 Million
Q3 2017 Oct 20, 2017	BUY	$129.47 - $135.38 $24.2 Million - $25.3 Million	186,866	186,866 $24.3 Million

Others Institutions Holding JNJ

# of Institutions

4,275

Shares Held

1.68B

Call Options Held

17.6M

Put Options Held

14.5M

View Full List

About JOHNSON & JOHNSON

Ticker JNJ
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,614,479,872
Market Cap $379B
Description
Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...

More about JNJ

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ingalls & Snyder LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ingalls & Snyder LLC with notifications on news.

Account

Ingalls & Snyder LLC Johnson & Johnson Transaction History